SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZinnwald Lithium Regulatory News (ZNWD)

Share Price Information for Zinnwald Lithium (ZNWD)

Share Price is delayed by 15 minutes
Get Live Data
8.75    0.25 (2.86%)
Bid:
8.50
Ask:
9.00
Spread: 0.50 (5.882%)
Market Cap: £42.71m
ZNWD Live PriceLast checked at - London Stock Exchange

Intraday Zinnwald Lithium Share Chart

Form 8.3 - AMG Lithium B.V.

11 Jun 2026 11:00

RNS Number : 9641H
D. E. Shaw & Co., L.P.
11 June 2026
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

D. E. Shaw & Co., L.P.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AMG Lithium B.V. (a direct wholly-owned subsidiary of AMG Critical Materials N.V.)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

10 June 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

EUR 0.02 ordinary

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,318

0.00%

9,298

0.02%

(2) Cash-settled derivatives:

593,389

1.66%

125,682

0.35%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

124,600

0.35%

120,500

0.33%

TOTAL:

719,307

2.02%

255,480

0.71%

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

EUR 0.02 ordinary

Swap

Increasing a long position

50

EUR 33.52

EUR 0.02 ordinary

Swap

Increasing a long position

22

EUR 33.68

EUR 0.02 ordinary

Swap

Increasing a long position

83

EUR 34.16

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

Yes

Β 

Β 

Date of disclosure:

11 June 2026

Contact name:

Harry Moule (Compliance Department)

Telephone number:

+44 (0) 20 7149 1033

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

Β 

Β 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

Β 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

Β 

Β 

1. KEY INFORMATION

Β 

Full name of person making disclosure:

D. E. Shaw & Co., L.P.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

AMG Lithium B.V. (a direct wholly-owned subsidiary of AMG Critical Materials N.V.)

Β 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Β 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

EUR 0.02 ordinary

Listed Call Option

Purchased

14,000

EUR 30.00

American

20260619

EUR 0.02 ordinary

Listed Call Option

Purchased

13,000

EUR 35.00

American

20261218

EUR 0.02 ordinary

Listed Call Option

Purchased

13,000

EUR 35.00

American

20270618

EUR 0.02 ordinary

Listed Call Option

Purchased

12,000

EUR 40.00

American

20260619

EUR 0.02 ordinary

Listed Call Option

Purchased

25,000

EUR 40.00

American

20270618

EUR 0.02 ordinary

Listed Call Option

Purchased

41,000

EUR 50.00

American

20271217

EUR 0.02 ordinary

Listed Call Option

Purchased

6,600

EUR 55.00

American

20271217

EUR 0.02 ordinary

Listed Put Option

Purchased

12,000

EUR 26.00

American

20270618

EUR 0.02 ordinary

Listed Put Option

Purchased

29,000

EUR 28.00

American

20260619

EUR 0.02 ordinary

Listed Put Option

Purchased

12,000

EUR 28.00

American

20270618

EUR 0.02 ordinary

Listed Put Option

Purchased

12,000

EUR 30.00

American

20270618

EUR 0.02 ordinary

Listed Put Option

Purchased

8,500

EUR 35.00

American

20271217

EUR 0.02 ordinary

Listed Put Option

Purchased

8,500

EUR 40.00

American

20271217

EUR 0.02 ordinary

Listed Put Option

Purchased

8,500

EUR 45.00

American

20271217

EUR 0.02 ordinary

Listed Put Option

Purchased

30,000

EUR 50.00

American

20270618

Β 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Β 

Full details should be given so that the nature of the interest or position can be fully understood:

Β 

None

Β 

Β 

Β 

Β 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETFIFEARSILLIR
Date   Source Headline
15th May 20237:00 amRNSNotice of AGM
25th Apr 202310:00 amRNSAppointment of Non-Executive Director
6th Apr 20232:44 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSHolding(s) in Company
29th Mar 20232:42 pmRNSHolding(s) in Company
29th Mar 202312:32 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSPresenting at Battery Gigafactories Europe 2023
23rd Mar 20232:05 pmRNSSecond Price Monitoring Extn
23rd Mar 20232:00 pmRNSPrice Monitoring Extension
23rd Mar 20238:11 amRNSIssuance of RSUs and Options
23rd Mar 20237:58 amRNSResult of fundraising
22nd Mar 20235:02 pmRNSRetail offer via PrimaryBid
22nd Mar 20235:01 pmRNSStrategic Investment and Equity Fundraising
22nd Mar 20235:00 pmRNSFinal Results
13th Mar 20237:00 amRNSOcean Partners UK Ltd to acquire Erris Zinc Ltd
23rd Feb 20233:00 pmRNSHolding(s) in Company
21st Feb 20234:40 pmRNSSecond Price Monitoring Extn
21st Feb 20234:35 pmRNSPrice Monitoring Extension
6th Feb 20237:00 amRNSTamesis as Joint Broker & Research Published
30th Jan 20237:00 amRNSPotential for Significant Li Resource @ Falkenhain
23rd Nov 20227:00 amRNSOperational Update
1st Nov 20227:00 amRNSMOU to develop sustainable mining operation
15th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNew Corporate Presentation
9th Sep 20224:00 pmRNSInvestor Presentation
9th Sep 20223:39 pmRNSHolding(s) in Company
8th Sep 20221:00 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSPEA - Robust Economics for German Lithium Project
5th Sep 20227:00 amRNSStart of Exploration Drilling at Falkenhain
4th Aug 20227:00 amRNSOption to Acquire Land
27th Jul 20227:00 amRNSStart of Drilling
23rd Jun 202211:37 amRNSResult of AGM
8th Jun 20227:00 amRNSOperational Update
7th Jun 20224:59 pmRNSHolding(s) in Company
26th May 20227:00 amRNSNotice of AGM
16th Mar 20221:17 pmRNSHolding(s) in Company
16th Mar 202210:10 amRNSNew Corporate Presentation
10th Mar 202212:00 pmRNSInvestor Presentation
8th Mar 20227:00 amRNSProven Viability of Lithium Hydroxide Production
22nd Feb 20227:00 amRNSFinal Results
14th Feb 202211:03 amRNSHolding(s) in Company
3rd Feb 20224:37 pmRNSHolding(s) in Company
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:38 pmRNSPrice Monitoring Extension
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:01 pmRNSPrice Monitoring Extension
18th Jan 202212:06 pmRNSHolding(s) in Company
17th Jan 20227:00 amRNSIssuance of RSUs and Options
5th Jan 202211:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.